BioSpace News Archive

Codiak BioSciences, Inc., a company at the forefront of advancing engineered exosomes as a new class of biologic medicines, today announced the first preclinical data for its engEx™ Platform program, exoASO™.

The Association of Physician Assistants in Oncology (APAO) and Horizon CME (HCME) jointly announce a partnership to provide education to the APAO membership through HCME’s Advanced Practice Provider (APP) Oncology Summit (APPOS) series and its associated online library

Technavio has announced its latest market research report titled global bariatric surgery devices market 2019-2023.

Liminal BioSciences Inc. announced the presentation of two scientific posters with new preclinical data for PBI-4050 and the treatment of pulmonary arterial hypertension at the American Heart Association 2019 conference taking place on November 16-18, 2019 in Philadelphia, PA..

Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. and certain of its officers.

BioCryst Pharmaceuticals, Inc. announced the completion of an underwritten public offering of 43,620,690 shares of its common stock, including 5,689,655 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares.

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., president and chief executive officer, is scheduled to present a corporate overview at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 1:20 p.m. GMT, in London.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has announced Antonio Pisani, MD, PhD, associate professor of neurology at the University of Rome Tor Vergata in Italy, and David G. Standaert, MD, PhD, John N. Whitaker Professor and chairman of neurology at The University of Alabama at Birmingham, as the recipients of the fifth annual Bachmann-Strauss Prize for Excellence in Dystonia Research.

Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine.

The iQ Group Global, an enterprise dedicated to developing early stage bioscience assets, announced that Dr. Jonathan Arambula will join The iQ Group Global as the Vice President of Research, OncoTEX Inc.